Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials.

CONCLUSIONS: Our fndings indicate that oral telithromycin and clarithromycin have similar treatment efficacy and adverse effect. The advantages of lower antimicrobial resistance rates, once-daily short-duration dosing and reported lower health-care costs make oral telithromycin a useful option for the empiric management of mild-to-moderate RTIs. PMID: 23769580 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23769580?dopt=Abstract

Source: Chinese Medical Journal - June 1, 2013 Category: Journals (General) Authors: Li XM, Wang FC, Yang F, Jin YH Tags: Chin Med J (Engl) Source Type: research